Top compounds associated with response to PXDN


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC 0.016 0.7
mRNA cabozantinib CTRPv2 pan-cancer AAC 0.016 0.7
mRNA MG-132 GDSC1000 pan-cancer AAC -0.023 0.7
mRNA KU-60019 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA Sorafenib GDSC1000 pan-cancer AAC -0.025 0.7
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.016 0.7
mRNA lenalidomide GDSC1000 pan-cancer AAC 0.015 0.7
mRNA PRIMA-1-Met CTRPv2 pan-cancer AAC 0.023 0.7
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.013 0.7
Download CSV